{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:11:02Z","timestamp":1792300262449,"version":"4.4.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,15]]},"DOI":"10.2146\/ajhp140288","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T18:19:20Z","timestamp":1422469160000},"page":"267-276","source":"Crossref","is-referenced-by-count":16,"title":["RhOD immune globulin products for prevention of alloimmunization during pregnancy"],"prefix":"10.1093","volume":"72","author":[{"given":"Samuel L.","family":"Aitken","sequence":"first","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Tichy","sequence":"additional","affiliation":[{"name":"Solid Organ Transplantation, and Director, Postgraduate Year 2 Residency, Department of Pharmacy Services, Yale\u2013New Haven Hospital, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041008220992700_b1-0720267","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2146\/ajhp080086","article-title":"ASHP guidelines on the pharmacy and therapeutics committee and the formulary system","volume":"65","author":"Tyler","year":"2008","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041008220992700_b2-0720267","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/j.1537-2995.2008.01800.x","article-title":"Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG","volume":"48","author":"Ayache","year":"2008","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019041008220992700_b3-0720267","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/asheducation-2009.1.185","article-title":"Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn","author":"Brinc","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key\n\t\t\t\t2019041008220992700_b4-0720267","first-page":"8","article-title":"The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation","volume":"8","author":"Liumbruno","year":"2010","journal-title":"Blood Transfus"},{"key":"key\n\t\t\t\t2019041008220992700_b5-0720267","first-page":"1245","article-title":"The pathogenesis and prevention of Rh immunization","volume":"97","author":"Zipursky","year":"1967","journal-title":"Can Med Assoc J"},{"key":"key\n\t\t\t\t2019041008220992700_b6-0720267","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood.V23.5.621.621","article-title":"Mechanisms of isoimmunization. I. The transplacental passage of fetal erythrocytes in homospecific pregnancies","volume":"23","author":"Cohen","year":"1964","journal-title":"Blood"},{"issue":"suppl 18","key":"key\n\t\t\t\t2019041008220992700_b7-0720267","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1998.tb10286.x","article-title":"The scientific basis of antenatal prophylaxis","volume":"105","author":"Urbaniak","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"key\n\t\t\t\t2019041008220992700_b8-0720267","first-page":"60","article-title":"The prevention of Rh-immunization","volume":"23","author":"Bowman","year":"1977","journal-title":"Can Fam Physician"},{"key":"key\n\t\t\t\t2019041008220992700_b9-0720267","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ja01207a034","article-title":"Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids","volume":"68","author":"Cohn","year":"1946","journal-title":"J Am Chem Soc"},{"key":"key\n\t\t\t\t2019041008220992700_b10-0720267","first-page":"1121","article-title":"WinRho: Rh immune globulin prepared by ion exchange for intravenous use","volume":"123","author":"Bowman","year":"1980","journal-title":"Can Med Assoc J"},{"key":"key\n\t\t\t\t2019041008220992700_b11-0720267","first-page":"CD007885","article-title":"Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy","volume":"1","author":"Okwundu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041008220992700_b12-0720267","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041008220992700_b13-0720267","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00062752-200111000-00017","article-title":"Intravenous Rh immune globulin for treating immune thrombocytopenic purpura","volume":"8","author":"Sandler","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"key\n\t\t\t\t2019041008220992700_b14-0720267","volume-title":"WinRho SDF (Rh0[D] immune globulin intravenous [human]) package insert","year":"2012"},{"key":"key\n\t\t\t\t2019041008220992700_b15-0720267","volume-title":"HyperRHO S\/D (Rh0[D] immune globulin intravenous [human]) package insert","year":"2012"},{"key":"key\n\t\t\t\t2019041008220992700_b16-0720267","volume-title":"RhoGAM (Rh0[D] immune globulin intravenous [human]) package insert","year":"2010"},{"key":"key\n\t\t\t\t2019041008220992700_b17-0720267","volume-title":"Rhophylac (Rh0[D] immune globulin intravenous [human]) package insert","year":"2012"},{"key":"key\n\t\t\t\t2019041008220992700_b18-0720267","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/bmj.1.5238.1486","article-title":"Experimental studies on the prevention of Rh haemolytic disease","volume":"1","author":"Finn","year":"1961","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t2019041008220992700_b19-0720267","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1172\/JCI103542","article-title":"The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms","volume":"36","author":"Jandl","year":"1957","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041008220992700_b20-0720267","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1471-4906(00)01801-9","article-title":"Mechanism of anti-D-mediated immune suppression\u2014a paradox awaiting resolution?","volume":"22","author":"Kumpel","year":"2001","journal-title":"Trends Immunol"},{"key":"key\n\t\t\t\t2019041008220992700_b21-0720267","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1537-2995.2006.00924_1.x","article-title":"On the immunologic basis of Rh immune globulin (anti-D) prophylaxis","volume":"46","author":"Kumpel","year":"2006","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019041008220992700_b22-0720267","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1471-0528.2003.02158.x","article-title":"Pharmacokinetics of anti-D IgG in pregnant RhD-negative women","volume":"110","author":"Bichler","year":"2003","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041008220992700_b23-0720267","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejogrb.2004.03.009","article-title":"Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin","volume":"117","author":"MacKenzie","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t2019041008220992700_b24-0720267","volume-title":"Prevention of Rh sensitization: report of a WHO scientific group","year":"1971"},{"key":"key\n\t\t\t\t2019041008220992700_b25-0720267","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0887-7963(87)70010-8","article-title":"Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures","volume":"1","author":"Bowman","year":"1987","journal-title":"Transfus Med Rev"},{"key":"key\n\t\t\t\t2019041008220992700_b26-0720267","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1471-0528.2005.00789.x","article-title":"The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin","volume":"113","author":"MacKenzie","year":"2006","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041008220992700_b27-0720267","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-3148.1996.tb00073.x","article-title":"A pharmacokinetic\/pharmacodynamic model for the action of anti-D immunoglobulin in effecting circulatory clearance of Rh D+ red cells","volume":"6","author":"Chapman","year":"1996","journal-title":"Transfus Med"},{"key":"key\n\t\t\t\t2019041008220992700_b28-0720267","first-page":"63","article-title":"ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, Oct 1990). Clinical management guidelines for obstetrician-gynecologists","volume":"66","author":"American College of Obstetrics and Gynecology","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"key\n\t\t\t\t2019041008220992700_b29-0720267","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/1471-0528.12175","article-title":"Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme","volume":"120","author":"Bolton-Maggs","year":"2013","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041008220992700_b30-0720267","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.205.1.71","article-title":"Rh-o (D) immune globulin (human). Evaluation in women at risk of Rh immunization","volume":"205","author":"Ascari","year":"1968","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041008220992700_b31-0720267","first-page":"CD000021","article-title":"Anti-D administration after childbirth for preventing Rhesus alloimmunisation","volume":"2","author":"Crowther","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041008220992700_b32-0720267","first-page":"1021","article-title":"Prevention of primary Rh immunization: first report of the Western Canadian trial, 1966\u20131968","volume":"100","year":"1969","journal-title":"Can Med Assoc J"},{"key":"key\n\t\t\t\t2019041008220992700_b33-0720267","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/bmj.4.5629.479","article-title":"Significance of Rh-sensitization during pregnancy: its relation to a preventive programme","volume":"4","author":"Godel","year":"1968","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t2019041008220992700_b34-0720267","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1471-0528.2004.00243.x","article-title":"A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant","volume":"111","author":"Jones","year":"2004","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041008220992700_b35-0720267","first-page":"623","article-title":"Rh isoimmunization during pregnancy: antenatal prophylaxis","volume":"118","author":"Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"key":"key\n\t\t\t\t2019041008220992700_b36-0720267","first-page":"627","article-title":"Antenatal prophylaxis of Rh isoimmunization: 28-weeks\u2019-gestation service program","volume":"118","author":"Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"key":"key\n\t\t\t\t2019041008220992700_b37-0720267","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(83)90232-5","article-title":"The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae","volume":"2","author":"Tovey","year":"1983","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041008220992700_b38-0720267","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016348409157011","article-title":"Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin","volume":"124","author":"Hermann","year":"1984","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"key\n\t\t\t\t2019041008220992700_b39-0720267","first-page":"101","article-title":"[Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region]","volume":"16","author":"Huchet","year":"1987","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"key\n\t\t\t\t2019041008220992700_b40-0720267","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/00016348909087688","article-title":"Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy","volume":"68","author":"Trolle","year":"1989","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t2019041008220992700_b41-0720267","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-3148.1995.tb00180.x","article-title":"Multicentre trial of antepartum low-dose anti-D immunoglobulin","volume":"5","author":"Lee","year":"1995","journal-title":"Transfus Med"},{"key":"key\n\t\t\t\t2019041008220992700_b42-0720267","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/bmj.315.7122.1588","article-title":"Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme","volume":"315","author":"Mayne","year":"1997","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041008220992700_b43-0720267","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1471-0528.1999.tb08304.x","article-title":"Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study","volume":"106","author":"MacKenzie","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"key\n\t\t\t\t2019041008220992700_b44-0720267","doi-asserted-by":"crossref","first-page":"e30711","DOI":"10.1371\/journal.pone.0030711","article-title":"Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality","volume":"7","author":"Turner","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041008220992700_b45-0720267","first-page":"CD000020","article-title":"Anti-D administration in pregnancy for preventing Rhesus alloimmunisation","volume":"2","author":"Crowther","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041008220992700_b46-0720267","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0140-6736(69)92646-4","article-title":"Transplacental haemorrhage in spontaneous and induced abortion","volume":"1","author":"Matthews","year":"1969","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041008220992700_b47-0720267","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pd.1632","article-title":"Detection of fetomaternal hemorrhage following chorionic villus sampling by Kleihauer Betke test and rise in maternal serum alpha feto protein","volume":"27","author":"Katiyar","year":"2007","journal-title":"Prenat Diagn"},{"key":"key\n\t\t\t\t2019041008220992700_b48-0720267","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9378(85)90288-1","article-title":"Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?","volume":"151","author":"Bowman","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041008220992700_b49-0720267","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0140-6736(74)91305-1","article-title":"Letter: diagnostic amniocentesis and fetal-maternal bleeding","volume":"1","author":"Blajchman","year":"1974","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041008220992700_b50-0720267","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1471-0528.1975.tb00690.x","article-title":"Feto-maternal haemorrhage following successful and unsuccessful attempts at external cephalic version","volume":"82","author":"Marcus","year":"1975","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"key\n\t\t\t\t2019041008220992700_b51-0720267","first-page":"CD009617","article-title":"Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation","author":"Karanth","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041008220992700_b52-0720267","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1537-2995.1971.tb04424.x","article-title":"Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus","volume":"11","author":"Pollack","year":"1971","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019041008220992700_b53-0720267","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/bmj.3.5775.623","article-title":"Immunosuppressive therapy in Rh-incompatible transfusion","volume":"3","author":"Eklund","year":"1971","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t2019041008220992700_b54-0720267","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10017","article-title":"Improvement of the Kleihauer-Betke test by automated detection of fetal erythrocytes in maternal blood","volume":"54","author":"Pelikan","year":"2003","journal-title":"Cytometry B Clin Cytom"},{"key":"key\n\t\t\t\t2019041008220992700_b55-0720267","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/bmj.309.6949.240","article-title":"Value of Kleihauer testing after administration of anti-D immunoglobulin","volume":"309","author":"Duguid","year":"1994","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041008220992700_b56-0720267","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/01.TA.0000096654.37009.B7","article-title":"Kleihauer-Betke testing is important in all cases of maternal trauma","volume":"57","author":"Muench","year":"2004","journal-title":"J Trauma"},{"key":"key\n\t\t\t\t2019041008220992700_b57-0720267","unstructured":"Royal College of Obstetricians and Gynaecologists. Green-top guideline no. 22: the use of anti-D immunoglobulin for Rhesus D prophylaxis (April27, 2011). www.rcog.org.uk\/globalassets\/documents\/guidelines\/gtg22antidjuly2013.pdf (accessed 2014 Nov 4)."},{"key":"key\n\t\t\t\t2019041008220992700_b58-0720267","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1537-2995.1991.31491213292.x","article-title":"Detecting fetomaternal hemorrhage: a comparison of five methods","volume":"31","author":"Bayliss","year":"1991","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019041008220992700_b59-0720267","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/0002-9378(86)90725-8","article-title":"Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women","volume":"154","author":"Stedman","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041008220992700_b60-0720267","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1537-2995.1998.38898375514.x","article-title":"Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry","volume":"38","author":"Davis","year":"1998","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019041008220992700_b61-0720267","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1537-2995.2002.00137.x","article-title":"Quantification of fetomaternal hemorrhage by fluorescence microscopy is equivalent to flow cytometry","volume":"42","author":"Ochsenbein-Imhof","year":"2002","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019041008220992700_b62-0720267","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ajcp\/110.3.281","article-title":"Use of Rh immune globulin: ASCP practice parameter","volume":"110","author":"Hartwell","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t2019041008220992700_b63-0720267","unstructured":"U.S. Preventive Services Task Force. Screening for Rh (D) incompatibility (February2004). www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementFinal\/rh-d-incompatibility-screening (accessed 2014 Nov 4)."},{"key":"key\n\t\t\t\t2019041008220992700_b64-0720267","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/AOG.0b013e31829f8814","article-title":"Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis","volume":"122","author":"Hawk","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041008220992700_b65-0720267","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1701-2163(15)30864-1","article-title":"Cost-effectiveness of the management of rh-negative pregnant women","volume":"35","author":"Duplantie","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"key\n\t\t\t\t2019041008220992700_b66-0720267","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1423-0410.1979.tb04399.x","article-title":"McMaster conference on prevention of Rh immunization. 28\u201330 September, 1977","volume":"36","year":"1979","journal-title":"Vox Sang"},{"key":"key\n\t\t\t\t2019041008220992700_b67-0720267","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1471-0528.2004.00226.x","article-title":"The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative","volume":"111","author":"Chilcott","year":"2004","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041008220992700_b68-0720267","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1099-1050(199607)5:4<319::AID-HEC211>3.0.CO;2-6","article-title":"Cost-effectiveness of antenatal anti-D prophylaxis","volume":"5","author":"Vick","year":"1996","journal-title":"Health Econ"},{"key":"key\n\t\t\t\t2019041008220992700_b69-0720267","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1701-2163(16)35239-2","article-title":"Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?","volume":"34","author":"Koby","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"key\n\t\t\t\t2019041008220992700_b70-0720267","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5858\/133.3.465","article-title":"Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice","volume":"133","author":"Ramsey","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t2019041008220992700_b71-0720267","first-page":"1","article-title":"Bringing new rigor to RhIG calculations","author":"Paxton","year":"2008","journal-title":"CAP Today"},{"key":"key\n\t\t\t\t2019041008220992700_b72-0720267","doi-asserted-by":"crossref","first-page":"967","DOI":"10.5858\/2010-0095-LE.1","article-title":"Effectiveness of the RhIg dose calculator","volume":"134","author":"Sandler","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t2019041008220992700_b73-0720267","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/338787","article-title":"Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products?","volume":"34","author":"Chamberland","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019041008220992700_b74-0720267","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1054\/blre.2000.0129","article-title":"Reducing the risk of infection from plasma products: specific preventative strategies","volume":"14","author":"Burnouf","year":"2000","journal-title":"Blood Rev"},{"key":"key\n\t\t\t\t2019041008220992700_b75-0720267","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group","volume":"340","author":"Kenny-Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041008220992700_b76-0720267","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/01443610701469941","article-title":"The safety of RhIG in the prevention of haemolytic disease of the newborn","volume":"27","author":"Hirose","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"key\n\t\t\t\t2019041008220992700_b77-0720267","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2005.05796.x","article-title":"Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products","volume":"132","author":"Ludlam","year":"2006","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019041008220992700_b78-0720267","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041008220992700_b79-0720267","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041008220992700_b80-0720267","doi-asserted-by":"crossref","first-page":"e1002782","DOI":"10.1371\/journal.ppat.1002782","article-title":"Highly efficient prion transmission by blood transfusion","volume":"8","author":"Andreoletti","year":"2012","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t2019041008220992700_b81-0720267","doi-asserted-by":"crossref","first-page":"e23169","DOI":"10.1371\/journal.pone.0023169","article-title":"All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD","volume":"6","author":"McCutcheon","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041008220992700_b82-0720267","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2516.2010.02220.x","article-title":"Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders","volume":"16","author":"Millar","year":"2010","journal-title":"Haemophilia"},{"key":"key\n\t\t\t\t2019041008220992700_b83-0720267","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1537-2995.2011.03384.x","article-title":"RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)","volume":"52","author":"Despotovic","year":"2012","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019041008220992700_b84-0720267","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","article-title":"Intravenous immunoglobulin: adverse effects and safe administration","volume":"29","author":"Orbach","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"key\n\t\t\t\t2019041008220992700_b85-0720267","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1537-2995.2003.00519.x","article-title":"Intravenous immune globulins: an update for clinicians","volume":"43","author":"Knezevic-Maramica","year":"2003","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2019041008220992700_b86-0720267","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2337\/dc09-1822","article-title":"Review of adverse events associated with false glucose readings measured by GDH-PQQ-based glucose test strips in the presence of interfering sugars","volume":"33","author":"Frias","year":"2010","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041008220992700_b87-0720267","unstructured":"Food and Drug Administration. GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose monitoring technology (August13, 2009). www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm177295.htm (accessed 2013 Jul 7)."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/4\/267\/28320481\/ajhp0267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T21:33:33Z","timestamp":1651095213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/4\/267\/5111618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,15]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,2,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140288","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,2,15]]},"published":{"date-parts":[[2015,2,15]]}}}